Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism GPER1 degraders(G protein-coupled estrogen receptor 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | - | 24 Jan 2023 |